coronary-artery-disease

Documents about coronary-artery-disease

• Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study#398287ClinicalTrials.gov
• Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System#811594ClinicalTrials.gov
• Bioflow-DAPT Study#867931ClinicalTrials.gov
• Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)#881704ClinicalTrials.gov
• Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery#882521ClinicalTrials.gov
• Cross-over Study of Coronary Risk Factors With a Polypill#883656ClinicalTrials.gov
• Platform Therapeutic Education in Heart Failure and Coronary Disease#858420ClinicalTrials.gov
• Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention#264874IRIS
• Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I#800201ClinicalTrials.gov
• Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention#848842ClinicalTrials.gov
• Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)#866464ClinicalTrials.gov
• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease#846740ClinicalTrials.gov
• the Real-world Data of Risk Factor and Its Prognosis in PREmature Coronary ARtery DIseAse Study#877105ClinicalTrials.gov
• Emulation of Randomized Clinical Trial in Cardiovascular Disease#896841ClinicalTrials.gov
• Synergistic SGLT2 and GLP-1R targeting alleviates systemic inflammation-induced and M1 monocyte-driven endothelial dysfunction in coronary artery disease#468257HAL (France)
• Association and Prognostic Implications of Peripheral Arterial Disease and Calcific Aortic Stenosis#430167HAL (France)
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease#867661ClinicalTrials.gov
• Re-infusion of Unwashed Shed Blood During Off-pump Surgery#805389ClinicalTrials.gov
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions#828282ClinicalTrials.gov
• Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve#859235ClinicalTrials.gov
• Crossover vs Accurate Ostial PCI for Medina 0.0.1 and 0.1.0 Left Main Bifurcation Lesions#901308ClinicalTrials.gov
• Comparing predictive risk to actual presence of coronary atherosclerosis on coronary computed tomography angiography#331449ResearchOnline@ND
• Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis#828875ClinicalTrials.gov
• Image Content Analysis of Dural-axis Rotational Versus Standard Coronary Angiography#832463ClinicalTrials.gov
• Investigating genetic overlap between Alzheimer’s disease, lipids, and coronary artery disease: A large-scale genome-wide cross trait analysis#824167Research Online
• The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.#802922ClinicalTrials.gov
• Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.#835303ClinicalTrials.gov
• Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients#208383ClinicalTrials.gov
• Effect of Celecoxib on Markers of Vascular Inflammation#343721ClinicalTrials.gov
• Registry Experience at the Washington Hospital Center, DES - Xience V#803821ClinicalTrials.gov
• Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects#829326ClinicalTrials.gov
• Trial of MiStent Compared to Xience in Japan#851521ClinicalTrials.gov
• Functional Assessment in TAVI: FAITAVI#892800ClinicalTrials.gov
• ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes#217062ClinicalTrials.gov
• The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models#329498ClinicalTrials.gov
• ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation#802919ClinicalTrials.gov
• Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II#853586ClinicalTrials.gov
• Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality#870536ClinicalTrials.gov
• Self-apposing Stentys Stents Registry#877576ClinicalTrials.gov
• Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI#886875ClinicalTrials.gov
• The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial#804981ClinicalTrials.gov
• A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease#808014ClinicalTrials.gov
• Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS#808114ClinicalTrials.gov
• The Effect of Stress Ball Application Before Coronary Angiography on Stress, Anxiety and Vital Signs#825569ClinicalTrials.gov
• Preoperative Use of Fractional Flow Reserve in CABG Use and Effectiveness of FFR-based CABG in Real-life Practice#840198ClinicalTrials.gov
• PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)#879630ClinicalTrials.gov
• Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer#898198ClinicalTrials.gov
• Study of Value of Cardiac PET Scans With or Without CT Angiography and/or Measurement of Coronary Flow Reserve#850127ClinicalTrials.gov
• CCTA Coronary Hemodynamics, Systemic Inflammation and Vulnerable Plaques (COHESIVE)#889990ClinicalTrials.gov
• Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry#826929ClinicalTrials.gov